J2 Capital Management Inc

Position in JNJ — Johnson & Johnson

CIK 1586882 TROY, MI

Position in JNJ

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$702,227

+$685 QoQ

Shares Held

2,765

-3.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.56%

of 13F equity value

Holder Rank

#3,352

of 4,664 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

J2 Capital Management Inc holds $5,355,034 across 6 Drug Manufacturers - General names. JNJ ranks #4 (13.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	7,224	$1,817,847
2	LLY	ELI LILLY & Co	824	$988,330
3	MRK	Merck & Co., Inc.	6,147	$789,889
4	JNJ	Johnson & Johnson This page	2,765	$702,227
5	GSK	GSK plc	11,338	$594,337
6	GILD	Gilead Sciences, Inc.	3,660	$462,404

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$702,227	2,765	-3.7%	Shares	Sole	2026-07-20
2026-03-31	$701,542	2,870	-4.3%	Shares	Sole	2026-04-21
2025-12-31	$620,643	2,999	-4.7%	Shares	Sole	2026-01-20
2025-09-30	$583,516	3,147	-2.3%	Shares	Sole	2025-10-14
2025-06-30	$492,007	3,221	—	Shares	Sole	2025-07-21
No filing history on record for this holder in this stock.